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The 2012 annual meeting of the International Society for Stem Cell Research (ISSCR) marked the Tenth
Anniversary of the ISSCR. Held in Japan, the meeting showcased recent discoveries and surveyed the
remarkable progress that has been made in a decade of stem cell research.Over 3,500 attendees from 58 countries converged on Yoko-
hama, Japan, for the ISSCR Tenth Annual Meeting, June 13–16,
2012, to learn about the stateof theart of stemcell research span-
ning basic discoveries to clinical trials. No longer a fledgling, the
society, as well as the field in general, is maturing rapidly and
showing early signs of its long-touted therapeutic promise. This
was the first time the annualmeetingwas held in Japan, a country
with a firm commitment to the field of stem cell research. A high-
light of the meeting was a personal appearance by the Emperor
and Empress of Japan at a ceremony commemorating the
Tenth Anniversary of the ISSCR. The scientific core of the
meeting consisted of 7 plenary sessions and 20 concurrent
sessions spread over 5 days. Additionally, and in response to
a record number of abstract submissions, over 1,400 posters
were also presented. Here we review highlights of the plenary
presentations.
Pluripotency
The official program began with the Presidential Symposium
chaired by ISSCR President Fred Gage. The mayor of Yoko-
hama, Fumiko Hayashi, welcomed the attendees, and Rob and
Cheryl McEwen were presented with the ISSCR Public Service
Award. Rudolf Jaenisch (Whitehead Institute, USA), recipient of
the 2012 McEwen Award for Innovation, reviewed recent prog-
ress in the understanding of cellular reprogramming, providing
more evidence of how quickly this field is moving. While the
application of induced pluripotent stem cells (iPSCs) to model
complex human disease is gaining traction, the technology is still
evolving. Jaenisch underscored that while all somatic cells can
potentially be reprogrammed to an iPSC state, reprogramming
is a continuous, stochastic process, and variability in the level
and stoichiometry of the reprogramming factors make the
process highly inefficient. Not all iPSC clones are fully reprog-
rammed, and not all of them reach the same state. Analysis of
single-cell gene expression at different stages in the reprogram-
ming process is beginning to shed light on the mechanism ofreprogramming and was used to identify genes, for example,
Esrrb or Utf1, that are highly predictive of future iPSC colony
formation. Jaenisch presented a novel gene expression analysis
of reprogramming where a stochastic phase is followed by
a more deterministic phase of gene expression. He established
a Bayesian network that revealed a genetic hierarchy to reprog-
ramming.
Austin Smith (University of Cambridge, UK) described mouse
embryonic stem cells (ESCs) cultured in defined medium that
includes inhibitors of two kinases (MEK and GSK3), a condition
known as ‘‘2i’’ (Leitch et al., 2010). These growth conditions,
along with the cytokine leukemia inhibitory factor (LIF), establish
a self-renewing ground state with less morphological heteroge-
neity and more consistent expression of key pluripotency genes
than ESCs cultured in serum. Smith showed that the transcrip-
tome and epigenome profiles of serum- and 2i-grown ESCs
are quite distinct. A relative absence of lineage-related gene
expression in ESCs grown in 2i medium suggests that multiline-
age priming may be an induced condition and not an intrinsic
feature of self-renewing ESCs. The 2i conditions more effectively
block differentiation signals and may more accurately represent
the naive state of pluripotent cells in the inner cell mass of the
blastocyst. Furthermore, Smith was recently able to derive
embryonic germ cells from primordial germ cells reproducibly
and at a high efficiency in 2i conditions supplemented with LIF;
thus LIF and 2i were sufficient to rebuild pluripotency in this
unipotent population.
Kazutoshi Takahashi (Kyoto University, Japan) addressed the
subject of reprogramming errors and epigenetic memory in
iPSCs by comparing the global gene expression, DNA methyla-
tion, and exon sequences of over 50 human pluripotent stem cell
lines. For the most part, gene expression and epigenetic signa-
tures were comparable between pluripotent iPSC and ESC lines,
as was the ability to undergo neural differentiation. However,
a small fraction of iPSC clones were resistant to differentiation
and formed teratomas when transplanted into immune-deficientCell Stem Cell 11, 607–614, November 2, 2012 ª2012 ISSCR 607
Incoming ISSCR President Shinya Yama-
naka escorted the Emperor and Empress
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the Tenth Anniversary of the society. The
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subclones that produced differentiated cells and no teratomas,
as well as ‘‘bad’’ subclones. Microarray analysis of these clones
and subclones identified three genes that were consistently
upregulated in cells that did not differentiate. These genes con-
tained LTR promoters for human retroviruses. Takahashi
concluded that there appears to be epigenetic diversity among
iPSC clones, and further, that specific genes may serve as
markers for clones that are resistant to differentiation.
John Gurdon (The Gurdon Institute, UK) has been taking
advantage of the amphibian oocyte in order to analyze nuclear
reprogramming and identify mechanisms underlying an inherent
resistance to this process. His strategy is to transplant mamma-
lian cell nuclei into amphibian oocytes to study the mechanisms
of reactivation and silencing of embryonic genes and to identify
key oocyte reprogramming factors. There are significant differ-
ences between somatic nuclei obtained from cells of different
developmental stages in their resistance to oocyte reprogram-
ming. To understand the mechanisms underlying these differ-
ences, one approach is to progressively remove proteins and
RNA from somatic nuclei in order to determine those responsible
for resistance to reprogramming. These are thought to be
components that help stabilize the state of gene expression in
the differentiated states (Pasque et al., 2011). One conclusion
is that resistance to reprogramming in nuclear transfer experi-
ments is caused, at least in part, by restrictive histone marks
that block reactivation.
Tissue Formation and Cancer
Jane Visvader (Walter and Eliza Hall Institute, Australia) spoke
about themammary stemcell (MaSC) hierarchy in order to under-
stand the relationship between breast tissue stemandprogenitor
cells and the cells of origin of breast cancer. Similar to the hema-
topoietic system, a hierarchy of stem cells appears to exist within
the mammary gland, including unipotent and multipotent cells
that likely play different roles in the morphogenesis and mainte-608 Cell Stem Cell 11, 607–614, November 2, 2012 ª2012 ISSCRnance of the mammary epithelium (Van
Keymeulen et al., 2011). The mammalian
epithelial hierarchy consists of luminal
and myoepithelial lineages, and the
luminal lineage can be further subdivided
into ductal and alveolar sublineages.
Interestingly, MaSCs lack expression
of estrogen and progesterone receptors,
but are highly responsive to steroid
hormones. Using genome-wide tran-scriptomeanalysesofmammaryepithelial populations, a number
of potential mediators of hormone action were identified. Appar-
ently the morphogenic effects of steroid hormones on the
mammary gland occur through paracrine signaling, mediated,
at least in part, by luminal cell expression of RANK Ligand that
signals to MaSCs to increase their pool size (Asselin-Labat
et al., 2010). Hormone-stimulated expansion of the MaSC pool
helps explain the tumor-suppressing effects of ovariectomy
and antiestrogen compounds. Visvader recently extended these
studies by determining the epigenomes of primary mammary
epithelial subtypes. Epigenetic profiling of MaSCs, luminal
progenitors, and mature cells suggests that H3-K27 methylation
increases with lineage commitment. Moreover, H3-K27 methyl-
ation appears to be modulated by hormones. With H3-K27
methylation knocked out, progenitor proliferation decreases
and pregnancy-induced proliferation is lost. Furthermore, no
mammary growth was observed when H3-K27methylation-defi-
cient MaSCs were transplanted into the mammary fat pad, an
indication of reduced ‘‘stemness’’ potential. The demonstration
that hormones can induce changes in the epigenome may be
important not only for understanding normal breast function,
but also for understanding breast cancer.
Yoshiki Sasai (RIKEN Center for Developmental Biology,
Japan) presented a striking 3D, self-organized reconstruction
of the mouse and human retina arising from ESCs in culture.
Culture of mouse ESCs to form first retinal epithelium and then
a complex six-layered retinal structure, including a layer of
retinal pigment epithelia (RPE), demonstrated a self-driven
morphogenesis of the retinal epithelium, and confirmed that
the processes of optic vesicle evagination and formation of the
optic cup are internally programmed (Eiraku et al., 2011).
Sasai showed evidence that WNT signaling is responsible for
neural retina versus RPE patterning. When an ESC-derived optic
vesicle was cocultured with WNT3-expressing cells, both neural
retina and RPE were formed. Using this model, he went on
to show that autoregulatory secretion of a WNT inhibitor,
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tion. Conversely, WNT signaling in the proximal epithelium
suppresses expression of DKK1. This bistable mutual inhibitory
circuit between WNT and WNT inhibitor regulates neural retina
to RPE specification. Later, the distal epithelium expresses
FGFs that promote differentiation of neural retina at the cost of
RPE, stabilizing cell identity. In vivo, the self-organizing ability
of the developing retina is also coordinatedwith extrinsic signals,
such as FGFs from the cornea and lens, as well as WNTS from
the periocular mesenchyme. Sasai also proposed a relaxation-
expansion model to explain self-driven optic cup morphogen-
esis. The governing features include a relatively soft neural
retina, strong apical constriction at the hinge region, and enor-
mous expansion of the neural retina.
Sasai’s final topic concerned human retinal generation and
species-specific tissue mechanics. Sasai and colleagues were
able to generate a human ESC-derived optic cup in culture, con-
firming an intrinsic retinal morphogenesis program across
species (Nakano et al., 2012). However, the human retina was
much larger and thicker than the mouse retina, and took much
longer to form. Furthermore, the isolated human ESC-derived
NR demonstrated an intrinsic tendency to develop an apically
convex curvature, not observed in the mouse ESC-derived NR.
Apparently, eversion is dependent on beta-integrin signaling
from the basement membrane but does not require Rho/ROCK
signals. Neutralizing beta1-integrin antibody blocked eversion
and also altered apical basal cell patterning, a feature that
contributes to apical curvature. The overall message of this
talk was not only that a novel model exists for studies of eye
development, but also that 3D human ESC-derived tissues
can be produced in culture, with potential utility for disease
modeling, drug screening, toxicology, and cell-based therapy.
Elaine Fuchs (Rockefeller University, USA) presented a
panoramic view of the role of skin stem cells in homeostasis,
wound repair, and cancer. A key concern is how stem cells
in the epidermis, hair follicle, and sweat gland balance self-
renewal and differentiation. Similar to mammary glands, sweat
glands derive from epidermal progenitors, but they appear
to have limited tissue regenerative capacity. During develop-
ment, multipotent progenitors in the sweat ducts transition
to distinct unipotent progenitors, and following injury they
remain unipotent, so that healing occurs through activation
of epidermal, myoepithelial, and luminal-specific progenitors
(Lu et al., 2012).
Regeneration of hair follicles relies on the activation of
quiescent stem cells regulated through multiple signals,
including BMPs, WNTS, and FGFs. Fuchs addressed the role
of TGF-b signaling in this transition by describing a paracrine
transmitter, TGF-b2, produced by the dermal papilla that
activates transient Smad2/3 signaling in hair follicle stem cells.
Intracellular signaling pathways activated by growth factors
and niche signals appear to mediate the crosstalk between
dermal papilla and stem cells that brings the stem cells out of
quiescence. Fuchs described two approaches taken to identify
additional regulators of long-term skin stem cell self-renewal.
The first used RNAi to screen genes differentially regulated
in these cells, uncovering TBX1 as a modulator of stem cell
self-renewal in the hair follicle (Chen et al., 2012). Fuchs is also
doing a genome-wide screen using in utero intra-amnioticcavity injections of fluorescently labeled lentiviruses carrying
shRNA to achieve selective genetic alteration of epidermal
progenitors, thus enabling rapid assessment of gene function.
This year’s Ernest McCulloch Memorial Lecture was very
fittingly given by Irving Weissman (Stanford University, USA)
who discussed normal and neoplastic stem cells, building on
the classic work by Till andMcCulloch half a century ago. Weiss-
man described the poor outcome in metastatic breast cancer
patients given myeloablative therapy followed by autologous
mobilized peripheral blood transplants. He highlighted con-
tamination by circulating tumor cells as a cause, and presented
data supporting the strategy of ‘‘purifying’’ hematopoietic stem
cells (HSCs) to eliminate the cancer cells. In a small clinical trial
started in 1996, women with metastatic breast cancer treated
with high-dose chemotherapy followed by transplantation of
purified HSCs showed better than expected overall survival as
well as freedom from progression.
Weissman also discussed the clinical need for targeted deple-
tion of endogenous HSCs in order to facilitate their replacement
with allogeneic or gene-corrected stem cells. For example,
anti-CD117 (c-Kit) monoclonal antibody eliminates native
HSCs and facilitates engraftment of purified donor HSCs in a
mouse model of severe combined immunodeficiency (SCID)
(Czechowicz et al., 2007). More recently, a humanized anti-
human CD117 monoclonal antibody has been identified as
a potential candidate for the treatment of SCID. Weissman
ended his presentation with a glimpse at a very exciting potential
anticancer strategy emerging from the observation that CD47,
a ‘‘don’t eat me’’ signal that allows cells to evade phagocytosis
by macrophages, is overexpressed on a wide array of human
cancer cells. This defense can be breached by use of an anti-
CD47 antibody, a strategy that has been used to treat
acute myeloid leukemia, primary human lymphoma, and other
tumors in immune-deficient mice. Similarly, anti-CD47 anti-
bodies have inhibited the growth and prevented metastasis in
a range of orthotopically xenotransplanted human solid tumors
including ovarian, breast, colon, and brain (Willingham et al.,
2012). Targeting CD47 in human cancers is an attractive anti-
cancer strategy and plans are in place to move it rapidly to the
clinic.
Pathways to the Clinic
The last decade of research into the fundamental nature of stem
cells, progenitor cells, and their differentiated cell types has laid
the foundation for informed attempts to translate these findings
into new regenerative therapies. In a session on clinical transla-
tion, the opportunities and challenges for bringing new therapies
to patients were explored. A central theme that emerged in
this session was that preclinical studies are beginning to show
efficacy, and that initial introduction of stem cell derivatives
into human subjects can be safe. This session also explored
ethical issues surrounding stem cell treatments, including the
selection of subjects and use of unproven treatments.
Three presentations focusing on varying uses of neural stem
cells suggested promise in this important area. Ann Tsukamoto
(Stem Cells, Inc., USA) described a purified population of human
neural stem cells derived from the central nervous system that
can be expanded in vitro and banked. She presented data sug-
gesting that when introduced in vivo, these cells can proliferateCell Stem Cell 11, 607–614, November 2, 2012 ª2012 ISSCR 609
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cytes, and oligodendrocytes, and can also provide paracrine
support to neighboring cells. Initial trials in human patients with
Batten disease, a devastating lysosomal storage disease, have
shown safety of the cells. New trials in demyelinating disorders,
spinal cord injury, and age-related macular degeneration are
underway or soon to be started.
Unlike the organ-derived cells described by Tsukamoto,
Masayo Takahashi (RIKEN Center for Developmental Biology,
Japan) and Hideyuki Okano (Keio University, Japan) described
the potential use of iPSC-derived neural cells. Takahashi has
shown the efficient generation of RPE cells from human ESCs
and iPSCs that closely resemble endogenous RPE cells. These
are the cells that are defective in the wet form of age-related
macular degeneration (AMD), and Takahashi showed that
iPSC-derived RPEs can be transplanted in animal models of
AMD. So far, these cells have not formed tumors. The next hurdle
will be translating these findings into a human clinical trial, and
the enrollment for this trial should begin soon.
Similarly, Okano tested neural stem/progenitor cells derived
from multiple human iPSC lines, and injected them into a mouse
model of spinal cord injury. Interestingly, some of these iPSC
lines were tumorigenic, but others were not and could be
selected and tested in mice for safety. Use of neural progenitor
cells from the ‘‘safe’’ iPSC lines in a nonhuman primate model
of spinal cord injury revealed improved myelination, synapse
formation of iPSC-derived neurons with existing neurons, and
most importantly, improved locomotion in animals with spinal
cord injury. These studies hold promise but the issue of tumori-
genicity will need to be considered. Given the limited time
window for intervention after spinal cord injury, new approaches
for direct reprogramming of somatic cells to neuronal stem cells
may offer an attractive source of cells for transplantation.
Another cell type that has been used extensively in early
human clinical trials is the mesenchymal stromal cell (MSC).
Katarina Le Blanc (Karolinska Institute, Sweden) presented
a summary highlighting the overall safety of these cells when
they are introduced intravenously. MSCs may show benefit in
the treatment of some conditions, but while one hypothesis is
that they exert a paracrine effect that limits inflammatory
responses, the exact mechanism of their action remains
unknown. Determining the best methods of expanding and
growing MSCs and testing their efficacy in animal models of
human disease are both important steps that remain before their
true therapeutic potential can be fully assessed.
As stem cell therapies advance into people, the ethical
standards and implications deserve consideration. Jan Helge
Solbakk (University of Oslo, Norway) spoke to concerns of
‘‘rogue’’ stem cell clinics preying on patients. Many clinics
worldwide are offering unproven therapies without proper trials
but claiming ‘‘proven’’ efficacy. Rigorous ethical standards are
increasingly important as we go forward, and clear ways for
patients to determine if treatments are proven or being sold
without evidence will be critical. In addition, we need to consider
the populations that are tested with new therapies, how they
are selected, and how treatments are financed in an ethical
fashion. These and other ethical issues need to remain in the
forefront as clinical translation of stem cells accelerates in the
coming years.610 Cell Stem Cell 11, 607–614, November 2, 2012 ª2012 ISSCRSystems Biology, Epigenetics, and an Award
The availability of methods for mapping chromatin modifications
and transcription factor binding on a genome-wide level has had
a dramatic impact on ESC research. Bing Ren (University of
California, USA) pointed out how cis-regulatory sequences,
and a better understanding of their function and regulation, are
important to understand cell-type-specific expression patterns.
Ren reported conclusions from their epigenetic data mapping
survey of pluripotent cells (including iPSCs and ESCs) and
various differentiated cell types. Typically, chromatin modifica-
tions at promoters remain largely invariant during differentiation,
but distal regulatory regions, i.e., enhancers, display much
greater dynamics in chromatin modification, associated with
active chromatin marks in a cell-type-specific manner (Hawkins
et al., 2011). This agrees with the notion that enhancers are key
to the regulation of cell-type-specific expression patterns.
However, finding the gene that is regulated by a specific
enhancer is not straightforward because a significant number
of enhancers may not target the closest promoter. Ren added
a new wrinkle with the report that the genome is spatially orga-
nized into domains of coordinately regulated enhancers and
promoters (Shen et al., 2012). The invention of chromosome
conformation capture-based technologies has allowed the
mapping of DNA-DNA contacts in mammalian cells. Using Hi-C,
Ren demonstrated the existence of thousands of megabase-
sized chromosome interaction domains, termed topological
domains, which function as locally coregulated regions where
short range DNA-DNA contacts, i.e. those between enhancers
and promoters, occur (Dixon et al., 2012; Shen et al., 2012). A
recent report by Edith Heard’s laboratory showed that disruption
of a boundary between two of these topological domains caused
a dramatic change in long-range DNA contacts and widespread
transcriptional misregulation (Nora et al., 2012).
Anjana Rao (La Jolla Institute for Allergy & Immunology, USA)
reported new insights into the role of Tet proteins, their regula-
tion, and 5-methylcytosine (5mC) oxidation in ESCs and HSCs.
Tet enzymes diminish DNA methylation by converting 5mC to
5-hydroxymethylcytosine (5hmC) and additional oxidized prod-
ucts. Rao reviewed that both TET1 and TET2 are present in
ESCs, are regulated by OCT4, and are important for 5hmC
production in these cells and for their differentiation potential,
although double knockout mice are viable (Koh et al., 2011).
Using an approach that distinguishes 5hmC from 5mC, Rao
discussed the genome-wide distribution of 5hmC in ESCs
depleted for TET1 or TET2 and addressed how TET protein
stability is regulated (Pastor et al., 2011).
Huck Hui Ng (Genome Institute of Singapore, Singapore) pre-
sented an intriguing follow-up on his genome-wide RNAi screen
(Chia et al., 2010). For this screen, a GFP reporter driven byOct4
regulatory sequences was introduced into human ESCs, and
the knockdown of several hundred genes resulted in reduced
GFP reporter expression. While much attention has focused on
deciphering the role of transcription factors, chromatin regula-
tors, and signaling pathways in ESCs cells, Ng’s talk focused
on one of the factors identified in the screen that does not fall
into any of these classical categories. He revealed that a novel
spliceosome-associated RNA-binding factor is important for
the control of splicing of a subset of genes in ESCs. Together
with a report by Blencowe and colleagues (Gabut et al., 2011),
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splicing.
Cedric Blanpain (Universite´ Libre de Bruxelles, Belgium),
winner of the 2012 ISSCR-University of Pittsburgh Outstanding
Young Investigator Award, summarized his research focusing
primarily on the role of stem cells during epithelial homeostasis
and cancer initiation. He first described clonal analysis of inter-
follicular epidermis. It had been previously proposed that skin
homeostasis can be explained by the population dynamics of
a single stem cell type with no intermediate transit amplifying
population. Blanpain reinvestigated this issue using CreER
constructs driven by either Keratin 14 (K14) or Involucrin to follow
the fate of basal progenitor epidermal cells over time. He found
that clones marked by each of the two drivers had different
survival characteristics and size distributions. Bymathematically
modeling the population dynamics, Blanpain demonstrated the
existence of two distinct populations, one of slower cycling
stem cells (K14+) that gives rise to a second, faster-dividing
intermediate progenitor. Interestingly, the K14+ stem cell popu-
lation, but rarely the committed progenitors, participate in long-
term repair of the epidermis after wounding (Mascre´ et al., 2012).
In the second part of the talk, Blanpain focused on lineage
tracing in the mammary gland. During pregnancy and puberty,
K14 marks the myoepithelial mammary lineage and is unipotent.
Meanwhile, K8 marks the luminal lineage, which is likewise uni-
potent. In contrast, when cells are dissociated and used to
reconstitute mammary tissue in the fat pad, the myoepithelial
cells can reconstitute both myoepithelial and luminal cells (Van
Keymeulen et al., 2011).
Finally, the topic turned to cancer. Here, Blanpain used
genetic labeling of tumor cells and clonal analysis to dissect
the mode of tumor growth in squamous skin tumors (Driessens
et al., 2012). In benign papilloma, the majority of tumor cells
disappear, indicating that they behave as transient amplifying
progeny that are lost through differentiation, whereas a fraction
expand massively. This leads to a model where a cancer stem
cell is established that divides very quickly, but still undergoes
stochastic cell fate choices allowing self-renewal and differenti-
ation, reminiscent of the hierarchical organization of the normal
epidermis.When invasive squamous cell tumorswere examined,
some clones showed evidence of cell differentiation, while
others gave rise to all undifferentiated daughters, consistent
with the emergence of one population of tumor-initiating cells
with limited differentiation potential.
RNA Control of Stem Cell Behavior
Narry Kim (Seoul National University, South Korea) spoke about
the biochemical function of LIN28, a pluripotency factor ex-
pressed in ESCs. She showed that LIN28 suppresses Let7
microRNA accumulation by oligouridylation of Let7 RNA. This
oligouridylation blocks Let7 processing by Dicer, shunting it
to a degradation pathway. To find the enzymatic activity asso-
ciated with LIN28/Let7 responsible for oligouridylation, Kim
and colleagues analyzed proteins associated with pre-Let7 in
LIN28 transfected cells, and found that the noncanonical polyA
polymerase TUT4 is the uridylyl transferase that acts in concert
with LIN28 (Heo et al., 2009). In new work, she examined the
function of monouridylation and found that, in contrast to oli-
gouridylation, it enhances Dicer processing of the pre-micro-RNA. Finally, Kim described work examining targets of LIN28.
Through UV crosslinking and immunoprecipitation, she defined
the LIN28 target motif. Further functional studies showed that
LIN28 does not affect target mRNA abundance, but rather
reduces translational efficiency as assayed by ribosome foot-
print analysis.
Plenary Session VI continued with Yumiko Saga (National
Institute of Genetics, Japan) describing her work on the function
of NANOS2, an RNA-associated factor in germ cells. NANOS is
a zinc finger motif protein expressed in male germ cells starting
at E13.5 where it prevents meiosis by inhibiting Stra8 expression
until after birth (Suzuki and Saga, 2008). Examination of NANOS2
expression in postnatal testes, as well as lineage tracing using
a Nanos2 enhancer, showed that NANOS2 is also expressed in
the spermatogonial stem cells. Overexpression of NANOS2 in
spermatogonial stem cells prevents their further differentiation.
Interestingly, overexpression of NANOS2 in female germ cells
promotes expression of male germ cell features.
Cell and molecular analysis has shown that NANOS2 is
localized to P-bodies that are structures involved in mRNA
degradation. Of note, NANOS2 interacts with components of
the deadenylation complex involved in the initial step of RNA
degradation (Suzuki et al., 2010). New work looking for other
Nanos-interacting partners identified the RNA-binding protein
DND1. Examination of transcripts that coimmunoprecipitate
with NANOS2 showed 48 sequences from transcripts that are
also upregulated in the NANOS2 knockout mouse. These results
indicate that NANOS2 is essential for regulating abundance of
key transcripts in the male germline.
Attention then turned to epigenetic switches in breast cell
transformation and bistable switches in the maintenance of
cancer stem cells in a lecture given by Kevin Struhl (Harvard
University, USA). He made the point that an important class of
epigenetic switches is positive feedback loops that generate
a ‘‘heritable’’ state of transcription factor activity. It is the tran-
scription factors that then determine the pattern of histone
modification, laid down by recruiting chromatin-modifying activ-
ities. In the first part of his talk, Struhl described an inflammatory
feedback loop involved in SRC-mediated transformation of the
breast epithelial cell line MCF-10A. The initial SRC activation
triggers a series of changes resulting in activation of an inflam-
matory positive feedback loop involving activation of NFkB,
IL6, and LIN28, which normally inhibits LET7. Importantly, high
levels of IL6 also activate NFkB, establishing a positive inflam-
matory feedback loop (Iliopoulos et al., 2009).
In the second part, Struhl presented work analyzing how intra-
cellular communication between cancer stem cells (CSCs) and
non-cancer stem cells (NCSCs) via IL6 is critical for maintaining
a stable proportion of the two cell types in a population over time.
Struhl then further described the intracellular switch between
the CSC and NCSC states. CSCs downregulate microRNAs
128, 125b, 103, and 145 that normally regulate polycomb genes
SUZ12, BMI1, ZEB1/2, and KLF4. In turn, ZEB1/2 inhibits the
microRNAs, which results in a reinforcing circuit that acts as
a bistable switch (Polytarchou et al., 2012). Evidence indicates
that this circuitry is relevant in triple negative breast cancer,
where cells are low in thesemicroRNAs, resulting in upregulation
of these important targets. The talk ended describing work to
identify agents that would target CSCs that are resistant toCell Stem Cell 11, 607–614, November 2, 2012 ª2012 ISSCR 611
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selectively killing CSCs. Administration of metformin plus the
standard chemotherapy agents increased tumor regression
and prolonged remission in a mouse xenograft model (Iliopoulos
et al., 2011).
Stem Cell and Fate Control
In Plenary Session VII, the final session of the Yokohama annual
meeting, we heard exciting published and unpublished studies
on the regulation of intestinal, neural, and skin stem cells.
Using impressive animations, Hans Clevers (Hubrecht Insti-
tute, Netherlands) illustrated the behavior and lineage emer-
gence of intestinal epithelia from LGR5-expressing stem cells
(Leblond cells). LGR5 is part of the LRP-WNT-Frizzled receptor
complex and mediates Rspondin (Rspo)-enhancement of Wnt
signaling. Clevers’ laboratory has shown that Leblond cells are
long-lived and actively dividing and give rise to all cell types
that are constantly replaced in the villi of the intestinal epithelium.
Sorted individual LGR5-expresing cells cultured in the presence
of RSPO1 and other factors give rise to self-organizing organoids
called ‘‘miniguts.’’ Interestingly, and in collaboration with the
Watanabe laboratory, Clevers and colleagues showed that mini-
guts derived from single LGR5+ cells give rise to normal gut
epithelium after transplantation. The cells integrate and can
repair damaged epithelial lining. In vivo, Leblond cells sit next
to Paneth cells. LGR5+ cells cocultured with Paneth cells give
rise to miniguts with much higher efficiency compared to
LGR5+ cells alone. Clevers then described the use of these
miniguts for disease modeling and drug screening using cystic
fibrosis as a model. Finally, Clevers presented beautiful multi-
color lineage analysis that established that all 15 stem cells
present in the crypt of each villus divide and contribute to intes-
tinal lineages. However, with time, one stem cell per villus popu-
lates the entire crypt (Snippert et al., 2010). Interestingly, APC
loss in LGR5 progenitors results in progeny with normal appear-
ance, but in which Wnt signaling cannot turn off, giving rise to
lateral growth that forms polyps or adenomas. These adenomas
contain interspersed LGR5+ cells that serve as a population of
tumor stem cells. Collectively, this work illustrates the power of
somatic stem cells in normal tissue homeostasis, regeneration,
and the understanding of cancer.
Hongjun Song (Johns Hopkins University, USA) presented an
innovative new way to lineage trace the progeny of neural stem
cells in the adult hippocampus. A population of radial astrocytes,
also known as type I progenitors or radial glial-like cells, function
as the primary progenitors for the generation of new neurons in
the dentate gyrus of the hippocampus in the adult mammalian
brain. Using very low concentrations of tamoxifen in mice
carrying Nestin enhancer-CreER and a floxed reporter, Song’s
laboratory was able to label individual radial astrocytes and
show that these cells can give rise to neurons, astrocytes, or
other radial astrocyte cells (Bonaguidi et al., 2011). Interestingly,
this observation suggests that a small subpopulation of pro-
genitors in the adult brain is capable of both self-renewal and
multilineage differentiation. Clonal analysis suggests that about
70% of these cells generate progeny: neurons and astrocytes.
They also observed that about 16% of the clones at 1 month
and about 30% of the clones at 2 months no longer contained
a radial astrocyte, suggesting some level of stem cell depletion612 Cell Stem Cell 11, 607–614, November 2, 2012 ª2012 ISSCRwith age. These observations show that the behavior of stem
cells in the adult hippocampus is heterogeneous, dividing either
symmetrically to amplify the population of primary progenitors,
or asymmetrically to produce progeny that include astrocytes
and neurons, but not oligodendrocytes. Song went on to present
exciting new observations showing that radial astrocytes
respond tonically to GABA through GABAA receptors. Interest-
ingly, conditional depletion of this receptor on the radial astro-
cytes modified their clonal behavior and induced increased
symmetrical division. This is an exciting finding, suggesting
that the neurotransmitter concentration next to adult neural
stem cells may play an important role in regulating their behavior.
Specifically, GABA may regulate symmetrical versus asymmet-
rical division of primary progenitors and therefore control neuro-
genesis (Song et al., 2012).
Oliver Hobert (Columbia University, USA) presented a compre-
hensive approach to understanding the genetic control for
generation of neuronal diversity. UsingC. elegans, his laboratory
has determined the set of genes specifically expressed by ASE
gustatory neurons. Among these more than 1,000 genes, none
were unique to these cells, suggesting that a combinatorial
strategy is used tomake the different neuronal types (Etchberger
et al., 2007). Using transgenesis they identified minimal regula-
tory elements present in more than a dozen of the ASE-specific
transcripts. The identified ASEmotif was essential for expression
of transcription factors in these neurons. In addition, using muta-
genesis, they found a zinc finger transcription factor, che-1, that
is essential for the expression of an ASE-specific neuropeptide.
Loss of che-1 does not cause the loss of ASE neurons, but
results in the loss of the expression of ASE-specific genes. Inter-
estingly, che-1, which specifically binds the ASE motif, is exclu-
sively expressed in ASE neurons through an autoregulatory loop.
These results suggest that distinct features of a neuronal type
are due to regulatory elements commonly regulated by unique
transcription factors. Importantly, transcription factors similar
to che-1, essential for the regulation of a neuron-specific set of
genes, are also found in other C. elegans neuronal types:
terminal selector transcription factors. Misexpression of che-1
during neurogenesis induces the expression of ASE-specific
genes in other neurons. Interestingly, with the exception of
a few other chemosensory neurons, the ectopic expression of
che-1 induces transdifferentiation into ASE neurons only during
a restricted period of neurogenesis. Knockdown of lin-53 permits
the ectopic expression of ASE markers past this developmental
permissive period (Tursun et al., 2011). Interestingly, this induc-
tion was only observed in germ cells, and within a very specific
subpopulation of these cells, the mitotic germ cells. This talk
beautifully illustrated what could be a common genetic mecha-
nism of specification of different types of neurons. The surprising
observation that a subpopulation of germ cells is susceptible to
reprogramming into specific subtypes of nerve cells by elimina-
tion of single epigenetic factor is extremely interesting.
Finally, Fiona Watt (King’s College London, UK) delivered the
Anne McLaren Memorial Lecture. Watt discussed how engi-
neered extracellular matrix (ECM) influences human epidermal
stem cell fate. Using small engineered ECM islands, her labora-
tory previously showed that differentiation of epidermal progen-
itor cells is inversely related to the adhesion surface area they
are cultured on. This response to restriction in spreading is
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and c-FOS. This work was done with cells grown on glass that
has much higher stiffness compared to the natural environment
where epidermal stem cells reside. By creating polydimethylsi-
loxane substrates of varying stiffness linked to ECM compo-
nents, Watt showed evidence that substrate stiffness had no
effect on spreading or differentiation. Yet, when polyacrylamide
hydrogels were used to vary stiffness, they found that keratino-
cytes spread and remained undifferentiated on hard substrates,
but not on soft substrates (Trappmann et al., 2012). Interestingly,
this was due to the porosity of the hydrogel and consequent
differences in the anchoring of collagen and not related to stiff-
ness. Indeed, this work suggests that the low anchoring density
of the ECM in a porous substrate prevents integrin clustering,
resulting in decreased ERK activation, dampening JNK phos-
phatase, increasing AP1-dependent transcription, and driving
differentiation. These exciting findings highlight the importance
of physical cues in the environment in the activation of specific
signaling responses within stem cells.
Watt also presented recent data on chromatin regulators of
this same population of cells. siRNA-based genetic screens of
several hundred chromatin modifiers in human epidermal stem
cells revealed a network that includes EZH2, UHRF1, ING5,
BPTF, and SMARCA5. They find that these chromatin factors
regulate differentiation through two distinct gene sets including
integrin ECM receptors that mediate anchorage of epidermal
stem cells to their niche (Mulder et al., 2012). The work begins
to integrate epigenetic factor and specific matrix anchorage
properties of human epidermal stem cells in the regulation of
their differentiation.
Much has been accomplished in the last 10 years, most of it
not predictable at the time of the founding of the ISSCR. One
can only guess at the achievements of the next 10 years, but
the first inklings will be on view in Boston when the ISSCRmeets
there in 2013.REFERENCES
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